Starpharma Pty Ltd   Report issue

For profit Phase 1 Phase 3
Founded: Abbotsford Australia (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2006
NCT00370357
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

contracted to Starpharma Pty Ltd

Active Ingredients

Drugs in Phase 3 Trials (2)

metronidazole (flagyl) (2 trials)

spl7013 (VivaGel) (9 trials)

Drugs in Phase 1 Trials (1)

hydroxyethyl starch (voluven) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 1)

Herpes Genitalis (Phase 2)

HIV Infections (Phase 1)

Recurrence (Phase 3)

Vaginal Diseases (Phase 3)

Vaginosis, Bacterial (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 3